Carina M. Thomé

653 total citations
13 papers, 322 citations indexed

About

Carina M. Thomé is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Carina M. Thomé has authored 13 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Carina M. Thomé's work include Glioma Diagnosis and Treatment (6 papers), Cancer Mechanisms and Therapy (2 papers) and Brain Metastases and Treatment (2 papers). Carina M. Thomé is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer Mechanisms and Therapy (2 papers) and Brain Metastases and Treatment (2 papers). Carina M. Thomé collaborates with scholars based in Germany, Switzerland and Sweden. Carina M. Thomé's co-authors include Marcel Seiz, Wolfgang Wick, Paul Rácz, Christine Meyer, Norman L. Letvin, Klara Tenner‐Racz, Peter J. Anderson, Stuart F. Schlossman, Alexander Lammert and Hans‐Peter Hammes and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Acta Neuropathologica.

In The Last Decade

Carina M. Thomé

13 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carina M. Thomé Germany 9 99 85 66 57 51 13 322
C S Morris United Kingdom 8 28 0.3× 73 0.9× 32 0.5× 106 1.9× 36 0.7× 8 315
María José Alcaraz García Spain 11 30 0.3× 134 1.6× 84 1.3× 9 0.2× 41 0.8× 23 312
Kimberly Loesch United States 12 17 0.2× 124 1.5× 79 1.2× 163 2.9× 119 2.3× 17 417
A. Dufour Italy 13 20 0.2× 92 1.1× 215 3.3× 9 0.2× 27 0.5× 28 515
Eric C. Woolf United States 8 117 1.2× 238 2.8× 47 0.7× 49 0.9× 29 0.6× 18 565
Elizabeth Weisiger United States 5 13 0.1× 211 2.5× 232 3.5× 28 0.5× 14 0.3× 6 475
Justin Lin United States 7 6 0.1× 156 1.8× 83 1.3× 21 0.4× 221 4.3× 13 697
Linda M. Kapp United States 12 19 0.2× 73 0.9× 182 2.8× 24 0.4× 23 0.5× 20 395
Amanda E. Au Australia 11 18 0.2× 203 2.4× 112 1.7× 5 0.1× 49 1.0× 16 470
Natascha Vidovic Germany 10 30 0.3× 53 0.6× 43 0.7× 33 0.6× 125 2.5× 15 326

Countries citing papers authored by Carina M. Thomé

Since Specialization
Citations

This map shows the geographic impact of Carina M. Thomé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carina M. Thomé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carina M. Thomé more than expected).

Fields of papers citing papers by Carina M. Thomé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carina M. Thomé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carina M. Thomé. The network helps show where Carina M. Thomé may publish in the future.

Co-authorship network of co-authors of Carina M. Thomé

This figure shows the co-authorship network connecting the top 25 collaborators of Carina M. Thomé. A scholar is included among the top collaborators of Carina M. Thomé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carina M. Thomé. Carina M. Thomé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kiesel, Barbara, Carina M. Thomé, Tobias Weiß, et al.. (2020). Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee. BMC Cancer. 20(1). 410–410. 15 indexed citations
2.
Brand, Frank, Carina M. Thomé, Marc S. Raab, et al.. (2019). FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas. Acta Neuropathologica. 139(1). 175–192. 16 indexed citations
3.
Berberich, Anne, Tobias Keßler, Carina M. Thomé, et al.. (2018). Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib. Clinical Cancer Research. 25(1). 253–265. 50 indexed citations
4.
Kerschbaumer, Johannes, Christian F. Freyschlag, Daniel Pinggera, & Carina M. Thomé. (2018). P01.154 Volumetric response to TTFields in newly diagnosed GBM. Neuro-Oncology. 20(suppl_3). iii268–iii268. 1 indexed citations
5.
Hertenstein, Anne, Sara Chiblak, Thomas Hielscher, et al.. (2017). P08.19 Resistance towards the MDM2 inhibitor idasanutlin is mediated via the NFkB pathway and IGFBP1 upregulation in glioblastoma. Neuro-Oncology. 19(suppl_3). iii58–iii58. 1 indexed citations
6.
Sonner, Jana K., Katrin Deumelandt, Martina Ott, et al.. (2016). The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas. OncoImmunology. 5(12). e1240858–e1240858. 50 indexed citations
7.
Thomé, Carina M., Jonas Blaes, Jana K. Sonner, et al.. (2016). OS1.3 N-Myc downstream regulated gene 1 (NDRG1) influences the glioma tumor microenvironment. Neuro-Oncology. 18(suppl_4). iv2–iv3. 1 indexed citations
8.
Broggini, Thomas, Christoph Harms, Jonas Blaes, et al.. (2015). NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment. Cancer Letters. 380(2). 568–576. 16 indexed citations
9.
Lilja, Anna M., Carina M. Thomé, Elisa Storelli, et al.. (2013). Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-β Levels. PLoS ONE. 8(3). e58752–e58752. 37 indexed citations
10.
Griesinger, Frank, et al.. (2011). [Treatment strategies for the multidisciplinary management of spinal metastasis].. DMW - Deutsche Medizinische Wochenschrift. 136(38). 1907–12. 3 indexed citations
11.
Freyschlag, Christian F., Jochen Tuettenberg, Frank Lohr, et al.. (2011). Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma.. PubMed. 31(3). 1023–5. 13 indexed citations
12.
Seiz, Marcel, Alexander Lammert, Marc A. Brockmann, et al.. (2010). SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases. Experimental and Clinical Endocrinology & Diabetes. 118(10). 760–763. 57 indexed citations
13.
Tenner‐Racz, Klara, Paul Rácz, Carina M. Thomé, et al.. (1993). Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients.. PubMed. 142(6). 1750–8. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026